Novartis radioligand therapy Lutathera® FDA approved as
Approval based on NETTER-P trial in which Lutathera demonstrated a consistent safety profile and comparable drug exposure between pediatric (ages ...
Read moreApproval based on NETTER-P trial in which Lutathera demonstrated a consistent safety profile and comparable drug exposure between pediatric (ages ...
Read moreSØBORG, Denmark, April 12, 2024 (GLOBE NEWSWIRE) -- Cbio A/S – Pioneering Next-Gen T-Cell Therapies for Solid Tumors, Unveils 2023 ...
Read moreWysa announces the successful development and launch of its leading conversational AI for mental health in Hindi. Wysa Hindi ...
Read moreEINDHOVEN, the Netherlands, Jan. 25, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative ...
Read more– KRIYA-586 is designed to be a one-time treatment delivered by focal peribulbar injection, that encodes an antibody blocking the ...
Read moreKaivalyadhama and Tata Memorial Centre Join Hands in a Landmark MoU to Enhance the Well-being of Cancer Survivors through Yoga ...
Read moreBANGALORE, India, Dec. 22, 2023 /PRNewswire/ -- Hairline International Hair and Skin Clinic, one of the leading hair clinics, announces the ...
Read moreLouvain-La-Neuve, Belgium, December 21, 2023 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and ...
Read morePhase III KATHERINE results reinforce Kadcyla as the standard of care for this population, with more than 82,000 people treated ...
Read morePress release, Helsinki, 14 November 2023, at 12:30 PM (EET) Nexstim Receives First Order for NBS 6 Therapy System in ...
Read more© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.
© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.